Our recombinant insulin is a key component in serum free growth media for mammalian cells.
Every year, we at Novo Nordisk Pharmatech publish a single, integrated report on our performance.
Read the Annual Report 2019 here and learn more about our accomplishments and results, our way of doing business and our financial statements.
Novo Nordisk Pharmatech A/S
Københavnsvej 216 DK - 4600 Køge
Phone: +45 5667 1000
Fax: +45 5667 1001
For complaints or comments about our company or our products, please contact